Evidence map›Paper›PMID 38891819›Full record

ReviewInternational journal of molecular sciences2024

Noble Metal Nanoparticle-Based Photothermal Therapy: Development and Application in Effective Cancer Therapy.

Shujie Yu, Guoyu Xia, Nan Yang, Longlong Yuan, Jianmin Li, Qingluo Wang, Dingyang Li, Lijun Ding, Zhongxiong Fan, Jinyao Li

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Advances in Photothermal Therapy for Oral Cancer.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shujie YuSchool of Pharmaceutical Sciences and Institute of Materia Medica, Xinjiang University, Urumqi 830017, China.
Guoyu XiaCollege of Life Science and Technology, Xinjiang University, Urumqi 830000, China.
Nan YangSchool of Pharmaceutical Sciences and Institute of Materia Medica, Xinjiang University, Urumqi 830017, China.
Longlong YuanCollege of Life Science and Technology, Xinjiang University, Urumqi 830000, China.
Jianmin LiCollege of Life Science and Technology, Xinjiang University, Urumqi 830000, China.
Qingluo WangCollege of Life Science and Technology, Xinjiang University, Urumqi 830000, China.
Dingyang LiCollege of Life Science and Technology, Xinjiang University, Urumqi 830000, China.
Lijun DingCollege of Life Science and Technology, Xinjiang University, Urumqi 830000, China.
Zhongxiong FanSchool of Pharmaceutical Sciences and Institute of Materia Medica, Xinjiang University, Urumqi 830017, China.ORCID 0000-0001-5751-9530
Jinyao LiCollege of Life Science and Technology, Xinjiang University, Urumqi 830000, China.ORCID 0000-0002-3295-6096

Funding

the Key research and development program in Xinjiang Uygur Autonomous Region 2023B02030, 2023B02030-1
6 · The paper itself

Abstract

Photothermal therapy (PTT) is a promising cancer therapy modality with significant advantages such as precise targeting, convenient drug delivery, better efficacy, and minimal adverse effects. Photothermal therapy effectively absorbs the photothermal transducers in the near-infrared region (NIR), which induces the photothermal effect to work. Although PTT has a better role in tumor therapy, it also suffers from low photothermal conversion efficiency, biosafety, and incomplete tumor elimination. Therefore, the use of nanomaterials themselves as photosensitizers, the targeted modification of nanomaterials to improve targeting efficiency, or the combined use of nanomaterials with other therapies can improve the therapeutic effects and reduce side effects. Notably, noble metal nanomaterials have attracted much attention in PTT because they have strong surface plasmon resonance and an effective absorbance light at specific near-infrared wavelengths. Therefore, they can be used as excellent photosensitizers to mediate photothermal conversion and improve its efficiency. This paper provides a comprehensive review of the key role played by noble metal nanomaterials in tumor photothermal therapy. It also describes the major challenges encountered during the implementation of photothermal therapy.

Indexed as

Metal NanoparticlesNeoplasmsPhotothermal TherapyAnimalsHumansPhotosensitizing AgentsPhotosensitizing Agentscombination therapynoble metal nanomaterialsphotothermal therapytumor therapy

Identifiers

PMID38891819
PMCPMC11172079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.